Key Statistics for SOM
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (AUD) (ttm)
|Est. EPS (AUD) (06/2014)
|Est. PEG Ratio
|Market Cap (M AUD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SOM
- Net Income (M/AUD)
Somnomed Limited manufactures, develops and markets the SomnoMed MAS which is a device used for the treatment of obstructive sleep apnea and snoring. The product is distributed to affected patients via accredited dentists.
More Company Profile & Key Executives for SOM
|Peter NeustadtChairman||Neil Verdal-AustinChief Financial Officer|
|Christopher BedfordGen Mgr:Production & Tech||Terence A Flitcroft "Terry"Secretary|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.